Imunon(IMNN) - 2024 Q1 - Earnings Call Transcript

Michael Tardugno Thank you, Stacy. On behalf of our shareholders and employees, welcome. We look forward to your leadership in this challenging and exciting world of biotech. Now to you, our shareholders and listening audience, I want to assure you that during our management transition, we remain wholly committed to advancing our two key platforms, as Stacy mentioned, TheraPlas and PlaCCine. As you know, it's a particularly important time as we look forward to reporting top line results from our Phase 2 stu ...